Talk:Remdesivir

Latest comment: 5 months ago by Bon courage in topic Semi-protected edit request on 28 January 2024
WikiProject iconChemicals High‑importance
WikiProject iconThis article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.
HighThis article has been rated as High-importance on the project's importance scale.
WikiProject iconViruses High‑importance
WikiProject iconThis article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
HighThis article has been rated as High-importance on the project's importance scale.
WikiProject iconCOVID-19 High‑importance
WikiProject iconThis article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.
HighThis article has been rated as High-importance on the project's importance scale.
WikiProject iconMedicine Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
MidThis article has been rated as Mid-importance on the project's importance scale.

Semi-protected edit request on 2 October 2023

Remdesivir is an antiviral agent with positive effects on the prognosis of Coronavirus Disease (COVID-19). However, there are concerns about the detrimental effects of remdesivir on kidney function which might consequently lead to Acute Kidney Injury (AKI).13 Apr. 2023https://www.ncbi.nlm.nih.gov › pmcAcute kidney injury in COVID-19 patients receiving remdesivir - NCBI 102.130.28.14 (talk) 08:38, 2 October 2023 (UTC)

 Not done No source linked. Bon courage (talk) 08:46, 2 October 2023 (UTC)
presuming you mean https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099148/ this, their conclusion was "Our study suggested that remdesivir treatment probably has little or no effect on the risk of AKI in COVID-19 patients." Cannolis (talk) 11:49, 2 October 2023 (UTC)

A little late here but,

I was surprised reading this article that there was very little mention of any of the past criticism of this drug. It sounds like it has had a lot of supporters and detractors since 2020, yet there is very little mention of any of the previous criticism (a couple sentences from what I read). The WHO recently walked back their criticism of the drug WHO recommends against the use of remdesivir in COVID-19 patients

And another recent article supports its use, along with the trials that WHO cites"Study Supports Use of Remdesivir for COVID-19 Patients on Low-Flow Oxygen or No Oxygen (hopkinsmedicine.org)"

So my question is:if the general scientific consensus has agreed that Remdesivir does work, does that mean there is little need of much discussion on any previous detractions or concerns about its quick approval?I would be of the opinion that the FDA not convening outside panels for this drug is notable, but I would like to know what this articles frequent editors think. (more sources: forbes and science.org) 134.134.139.84 (talk) 18:57, 11 October 2023 (UTC)

Any good sources giving an overview? So far as I can see the modern view is that remdesevir is a bit rubbish for COVID.[1] Bon courage (talk) 19:14, 11 October 2023 (UTC)

Semi-protected edit request on 28 January 2024

Possible side effects include death. 73.121.109.117 (talk) 11:52, 28 January 2024 (UTC)

 Not done No source. Bon courage (talk) 12:06, 28 January 2024 (UTC)